Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine for Prevention of Facial Numbness in Trigeminal Neuralgia SRS
NCT01364259Phase 3Terminated
- Sponsor
- Stanford University
- Start
- Sep 2008
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amifostine in trigeminal neuralgia (TN), sponsored by Stanford University. Started Sep 2008; status: terminated.
02
Drugs
amifostine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT01364259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364259.